T1	Premise 1087 1245	Participants in the intervention group reported, on average, 53 fewer days of sick leave over the first 6 months post-surgery than those in the control group;
T2	Premise 1246 1355	however, this difference was not statistically significant (p = 0.122; 95% confidence interval -15.8, 122.0).
T3	Premise 1356 1431	No statistically significant differences were found for secondary outcomes.
T4	Premise 1432 1579	Interviews with trial participants indicated that trial procedures, including recruitment, randomisation and research instruments, were acceptable.
T5	Claim 1580 1702	Conducting a pragmatic trial of effectiveness of a VR intervention among cancer survivors is both feasible and acceptable,
T6	Claim 1703 1829	but more research about the exact components of a VR intervention and choice of outcomes to measure effectiveness is required.
T7	MajorClaim 1830 1951	VR to assist breast cancer patients in the return to work process is an important component of cancer survivorship plans.
R1	Attack Arg1:T2 Arg2:T1	
R2	Partial-Attack Arg1:T6 Arg2:T5	
R3	Support Arg1:T4 Arg2:T5	
R4	Support Arg1:T1 Arg2:T5	
